Meeting on lessons learnt from sartan medicines containing N-nitrosamine impurities

Date: 04/11/2019
Location: European Medicines Agency, Amsterdam, the Netherlands

The European Medicines Agency organised a meeting to discuss lessons learnt from recent cases of sartan (angiotensin receptor blockers) medicines containing N-nitrosamine impurities. It discussed how to better prevent and manage cases of medicines with N-nitrosamine impurities in the future.

The meeting brought together patients and healthcare professional organisations, industry associations and European Union and international regulatory authorities.


How useful was this page?

Add your rating
3 ratings